Page last updated: 2024-08-23

paclitaxel and Agranulocytosis

paclitaxel has been researched along with Agranulocytosis in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	23 (63.89)	18.2507
2000's	11 (30.56)	29.6817
2010's	1 (2.78)	24.3611
2020's	1 (2.78)	2.80

Authors

Authors	Studies
Li, L; Song, C; Sun, Z; Wang, W; Xu, H; Yin, J	1
Chudy, B; Łata, S	1
Blood, E; Friedenberg, WR; Graham, D; Greipp, P; Winston, RD	1
Balat, O; Ugur, MG	1
Chida, M; Honma, H; Ishioka, S; Kudo, R; Mizumoto, H; Sagae, S; Saito, T; Tanaka, R; Terasawa, K	1
Kobayashi, Y; Moritake, T; Nagashima, T; Ogura, H; Seiki, T; Terauchi, F; Yamamoto, Y	1
Benner, SE; Hong, WK; Huber, MH; Lippman, SM	1
Dreicer, R; Einhorn, LH; Hudes, GR; Johnson, DH; Loehrer, PJ; Neuberg, D; Roth, BJ; Schultz, SM; Smith, JL	1
Ajani, JA; Daugherty, K; Ilson, DH; Kelsen, DP	1
Comis, R; Langer, CJ; Leighton, J; McAleer, C; O'Dwyer, P; Ozols, R	1
Bonjo, CA; Comis, RL; Engstrom, PF; Langer, CJ; Leighton, JC; Litwin, S; McAleer, CA; O'Dwyer, PJ; Ozols, RF	1
Bitran, JD; Drinkard, LC; Golomb, HM; Hoffman, PC; Krauss, SA; Masters, GA; Samuels, BL; Vokes, EE; Watson, S	1
Bates, S; Berg, SL; Bryant, G; Fojo, A; Goldspiel, BR; Herdt, J; O'Shaughnessy, J; Steinberg, SM; Wilson, WH; Wittes, RE	1
Abbruzzese, JL; Ajani, JA; Bready, B; Lassere, Y; Levin, B; Patt, Y; Pazdur, R; Soh, LT; Soo, E; Sugarman, S	1
Arioka, H; Eguchi, K; Karato, A; Kunikane, H; Nishio, M; Ohe, Y; Omatsu, H; Sasaki, Y; Shinkai, T; Tamura, T	1
Balcerzak, SP; Benedetti, J; Natale, RB; Weiss, GR	1
Nishiwaki, Y; Saijo, N; Sasaki, Y; Tamura, T	1
Bauknecht, T; Bochtler, H; Diergarten, K; du Bois, A; Köchli, O; Kreienberg, R; Kühnle, H; Lück, HJ; Meerpohl, HG; Möbus, V	1
DeVore, R; Hande, KR; Johnson, DH; Paul, DM	1
Bonomi, P; Faber, LP; Lincoln, S; Recine, D; Sharma, M; Siddiqui, S; Warren, W	1
Batist, G; Eisenhauer, E; Fisher, B; Hoskins, P; Onetto, N; Pike, J; Stuart, G; Swenerton, K	1
Blanc, C; Bruno, R; de Boer-Dennert, M; Harteveld, M; Hilkens, PH; Ma, J; Planting, AS; Pronk, LC; Schellens, JH; Stoter, G; van den Bent, MJ; van der Burg, ME; Verweij, J	1
Bamberg, M; Belka, C; Bochtler, H; Budach, W; Hess, CF; Hoffmann, W; Schmidberger, H	1
Hassan, M; Hoppel, C; Mackay, W; McGloin, B; Mugharbil, A; Olmsted, L; Sharan, V; Steinberg, L; Stepnick, D; Strauss, M; Subramanyan, S	1
Armstead, B; Fox, K; Holroyde, C; Malkowicz, SB; Mick, R; Ramchandani, P; Vaughn, DJ; Wein, A; Zoltick, B	1
Miyata, Y; Nakanomyo, H; Nishiwaki, Y; Ohtsu, T; Saijo, N; Sasaki, Y; Tamura, T	1
Kerkhofs, L; Kok, TC; Siersema, PD; Splinter, TA; Tilanus, HW; van der Gaast, A	1
Bajorin, DF; Boyle, MG; Dodd, PM; Herr, H; Hilton, S; Icasiano, E; Kelly, WK; Mazumdar, M; McCaffrey, JA	1
Blay, JY; Bouabdallah, K; Caillot, D; Casasnovas, RO; Dumontet, C; Gabarre, J; Gisselbrecht, C; Haioun, C; Lederlin, P; Morel, P; Quesnel, B; Richard, B; Stamatoullas, A	1
Aravantinos, G; Dimopoulos, MA; Georgoulias, V; Gika, D; Karpathios, S; Moulopoulos, LA; Papadimitriou, CA; Stamatelopoulos, S	1
Besenval, M; D'Aloisio, S; Daigneault, L; Eisenhauer, E; Fisher, B; Forand, D; Gelmon, KA; Génier, L; Latreille, J; Lebecq, A; Tolcher, A; Vernillet, L	1
Agrawal, A; Allen, J; Goldman, FP; Grecula, JC; Rhoades, CA; Schuller, DE; Sharma, P; Smith, RE; Young, D; Zhang, H	1
Adams, GL; DeConti, RC; Forastiere, AA; Leong, T; Murphy, BA; Rowinsky, E; Vlock, DR	1
Albain, KS; Clark, JI; Fisher, S; Hantel, A; Kancharla, K; Millbrandt, L; Panganiban, J; Qamar, R	1
Bayssas, MM; Benvenuto, J; Bready, B; Fuentes, A; Jaiyesimi, I; Moore, D; Newman, BM; Newman, RA; Pazdur, R; Vreeland, F	1
Buzdar, AU; Forman, AD; Frye, DK; Holmes, FA; Hortobagyi, GN; Newton, LK; Raber, MN; Theriault, RL; Walters, RS	1

Trials

30 trial(s) available for paclitaxel and Agranulocytosis

Article	Year
The treatment of multiple myeloma with docetaxel (an ECOG study). Leukemia research, 2003, Volume: 27, Issue:8 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Humans; Male; Middle Aged; Multiple Myeloma; Paclitaxel; Salvage Therapy; Survival Analysis; Survival Rate; Taxoids; Thrombocytopenia; Treatment Failure	2003
Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck. Seminars in oncology, 1995, Volume: 22, Issue:5 Suppl 12 Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Female; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Premedication	1995
Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Anemia; Carcinoma, Transitional Cell; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Recombinant Proteins; Thrombocytopenia; Urinary Bladder Neoplasms	1994
Paclitaxel in the treatment of carcinoma of the esophagus. Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 6 Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Paclitaxel; Remission Induction; Survival Analysis	1995
Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer. Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 6 Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Thrombocytopenia	1995
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Survival Rate; Thrombocytopenia	1995
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer. Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 9 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Tolerance; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Recombinant Proteins; Remission Induction	1995
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:8 Topics: Adult; Aged; Agranulocytosis; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Mitoxantrone; Mouth Mucosa; Paclitaxel; Stomatitis	1994
Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Colorectal Neoplasms; Docetaxel; Drug Administration Schedule; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Taxoids	1994
Phase I and pharmacokinetic study of paclitaxel by 24-hour intravenous infusion. Japanese journal of cancer research : Gann, 1994, Volume: 85, Issue:10 Topics: Adolescent; Adult; Aged; Agranulocytosis; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Time Factors	1994
A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A Southwest Oncology Group study. Cancer, 1995, Dec-01, Volume: 76, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Prospective Studies; Remission Induction; Sarcoma; Thrombocytopenia	1995
Phase I study of paclitaxel by three-hour infusion: hypotension just after infusion is one of the major dose-limiting toxicities. Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:12 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Hypotension; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Paclitaxel; Pain; Peripheral Nervous System Diseases; Premedication	1995
Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer. Seminars in oncology, 1995, Volume: 22, Issue:6 Suppl 15 Topics: Adult; Aged; Agranulocytosis; Ambulatory Care; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Remission Induction; Safety; Thrombocytopenia	1995
Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46). Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Nausea; Neuralgia; Paclitaxel; Peripheral Nervous System Diseases; Survival Rate; Thrombocytopenia; Treatment Outcome; Vomiting	1996
A phase I study of bi-weekly paclitaxel/cisplatin as initial therapy for advanced ovarian cancer. A study of the National Cancer Institute of Canada Clinical Trials Group. Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:10 Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Survival Rate	1996
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:3 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasms; Paclitaxel; Taxoids; Vomiting	1997
Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer--results from a Phase I trial. International journal of radiation oncology, biology, physics, 1997, Jul-01, Volume: 38, Issue:4 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth Mucosa; Paclitaxel; Prospective Studies; Radiation-Sensitizing Agents; Stomatitis	1997
A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma. Seminars in oncology, 1997, Volume: 24, Issue:6 Suppl 19 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cells, Cultured; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mitotic Index; Paclitaxel; Survival Rate; Tumor Cells, Cultured	1997
Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1 Topics: Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Male; Middle Aged; Nervous System Diseases; Paclitaxel; Urologic Neoplasms	1998
Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion. Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:6 Topics: Agranulocytosis; Antineoplastic Agents, Phytogenic; Dexamethasone; Diphenhydramine; Dose-Response Relationship, Drug; Drug Hypersensitivity; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Leukocyte Count; Neoplasms; Paclitaxel; Ranitidine; Time Factors	1995
Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer. British journal of cancer, 1999, Volume: 80, Issue:7 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Nervous System Diseases; Paclitaxel; Thrombocytopenia	1999
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:4 Topics: Aged; Agranulocytosis; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Nausea; Paclitaxel; Remission Induction; Urologic Neoplasms; Vomiting	2000
Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte. Haematologica, 2000, Volume: 85, Issue:5 Topics: Adolescent; Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug Evaluation; Female; Hemorrhage; Humans; Infections; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paclitaxel; Recurrence; Survival Rate; Treatment Outcome	2000
Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study. Gynecologic oncology, 2000, Volume: 78, Issue:1 Topics: Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Endometrial Neoplasms; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Peripheral Nervous System Diseases; Taxoids	2000
Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Dec-15, Volume: 18, Issue:24 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Paclitaxel; Taxoids	2000
Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck. Cancer, 2000, Dec-15, Volume: 89, Issue:12 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Survival Analysis; Thrombocytopenia; Treatment Outcome	2000
Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-15, Volume: 19, Issue:4 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neutropenia; Paclitaxel	2001
Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 34, Issue:2 Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Survival Analysis; Taxoids; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine	2001
Phase I trial of Taxotere: five-day schedule. Journal of the National Cancer Institute, 1992, Dec-02, Volume: 84, Issue:23 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mouth Mucosa; Neoplasms; Paclitaxel; Taxoids; Treatment Outcome	1992
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. Journal of the National Cancer Institute, 1991, Dec-18, Volume: 83, Issue:24 Topics: Adult; Aged; Agranulocytosis; Alkaloids; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Doxorubicin; Drug Evaluation; Female; Heart Diseases; Humans; Methotrexate; Middle Aged; Muscular Diseases; Paclitaxel; Pain; Peripheral Nervous System Diseases; Remission Induction; Soft Tissue Neoplasms; Thrombocytopenia	1991

Other Studies

6 other study(ies) available for paclitaxel and Agranulocytosis

Article	Year
Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma. Drug design, development and therapy, 2022, Volume: 16 Topics: Agranulocytosis; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Immune Checkpoint Inhibitors; Lung; Lung Neoplasms; Male; Neoadjuvant Therapy; Paclitaxel; Thrombocytopenia	2022
[49 year old patient with staphylococcal sepsis caused by agranulocytosis after polychemotheraphy]. Przeglad lekarski, 2010, Volume: 67, Issue:5 Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Cisplatin; Female; Humans; Krukenberg Tumor; Middle Aged; Neoplasms, Unknown Primary; Ovarian Neoplasms; Paclitaxel; Sepsis; Staphylococcal Infections	2010
Prolonged stabilization of platinum/paclitaxel-refractory ovarian cancer with topotecan: a case report and review of the literature. Clinical and experimental obstetrics & gynecology, 2003, Volume: 30, Issue:2-3 Topics: Adenocarcinoma, Papillary; Agranulocytosis; Drug Resistance, Neoplasm; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Quality of Life; Topotecan	2003
[A pilot study of combined chemotherapy with paclitaxel, doxorubicin and cisplatin for endometrial cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:4 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Endometrial Neoplasms; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Paclitaxel; Pilot Projects; Thrombocytopenia	2004
A pilot study of weekly paclitaxel administration for patients with relapsed cervical cancer after heavy medication. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5 Topics: Agranulocytosis; Alopecia; Antiemetics; Antineoplastic Agents, Phytogenic; Cimetidine; Combined Modality Therapy; Dexamethasone; Diphenhydramine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hysterectomy; Infusions, Intravenous; Lymph Node Excision; Neoplasm Recurrence, Local; Paclitaxel; Pilot Projects; Survival Rate; Uterine Cervical Neoplasms	2005
Escalating paclitaxel doses combined with carboplatin/etoposide and thoracic radiotherapy as preoperative or definitive treatment for stage III non-small cell lung cancer. Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16 Topics: Agranulocytosis; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Paclitaxel; Pneumonia; Remission Induction; Treatment Outcome	1996